Molecular Pharmacology (USA), Ltd. (MLPH)

OTCMKTS · Delayed Price · Currency is USD
0.0008
0.00 (0.00%)
At close: Mar 6, 2026
79,900%
Market Cap 799.64K
Revenue (ttm) n/a
Net Income (ttm) -105.18K
Shares Out 999.55M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 900
Average Volume 116,545
Open 0.0008
Previous Close 0.0008
Day's Range 0.0008 - 0.0008
52-Week Range 0.0000 - 0.0097
Beta -0.42
RSI 49.29
Earnings Date n/a

About MLPH

Molecular Pharmacology (USA), Ltd., a development stage company, develops and commercializes pain and inflammation management products primarily in Australia and the United States. The company, through its subsidiary, Molecular Pharmacology Pty. Ltd., develops analgesic and anti-inflammatory molecule, known as Tripeptofen for the treatment of common every-day pain. Its products are available in various dosage forms, formulations, line extensions, and package configurations. The company focuses on marketing its products through pharmaceutical di... [Read more]

Industry Shell Companies
Sector Financials
CEO Jeffrey Edwards
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol MLPH
Full Company Profile

Financial Performance

News

There is no news available yet.